Display screen or portion thereof with graphical user interface

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains at least one drawing/photograph executed in color. Copies of this patent with color drawing(s)/photograph(s) will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front view of a display screen or portion thereof with graphical user interface showing the claimed design; and,

FIG. 2 is a second embodiment thereof.

The outermost broken lines in the figures show a display screen or portion thereof, and form no part of the claimed design. The other broken lines in the figures form part of the claimed design.

Claims

The ornamental design for a display screen or portion thereof with graphical user interface as shown and described.

Referenced Cited
U.S. Patent Documents
D674401 January 15, 2013 Trumble
D694253 November 26, 2013 Helm
D716820 November 4, 2014 Wood
D753697 April 12, 2016 Dye
D775650 January 3, 2017 Zhao
D775664 January 3, 2017 Dye
D789968 June 20, 2017 Mensinger
D792890 July 25, 2017 Cruttenden
D800147 October 17, 2017 Kim
D815121 April 10, 2018 Cruttenden
D834595 November 27, 2018 Cruttenden
10136845 November 27, 2018 Taub
D864219 October 22, 2019 Farnan
D910687 February 16, 2021 Azzi
D917504 April 27, 2021 Cruttenden
11004566 May 11, 2021 Hayter
D934884 November 2, 2021 Bergenstal
D956062 June 28, 2022 Yuan
D967128 October 18, 2022 Kumar
D982606 April 4, 2023 Sun
D996457 August 22, 2023 Mozeika
D1001152 October 10, 2023 Kumar
20060277469 December 7, 2006 Chaudhri
20110201911 August 18, 2011 Johnson
20190121506 April 25, 2019 Matikyan
20220240819 August 4, 2022 Lee
Other references
  • Abbot Sanofi, by Conor Hale, Sep. 16, 2019, site (fiercebiotech.com) [online]. Retrieved from internet Nov. 26, 2024 <URL:https://www.fiercebiotech.com/medtech/easd-abbott-sanofi-to-interconnect-their-diabetes-monitoring-and-insulin-delivery-tech> (Year: 2019).
  • Algorithm Proves Better Than Humans, by Clara Rodriguez Fernandez, Oct. 3, 2018, site (labiotech.eu) [online]. Retrieved from internet Nov. 26, 2024 <URL:https://www.labiotech.eu/trends-news/artificial-pancreas-blood-sugar-diabetes/> (Year: 2018).
  • Insight into continuous glucose monitoring, by Ayman Chmayssem et al., Apr. 6, 2023, site (link.springer.com) [online]. Retrieved from internet Nov. 26, 2024 <URL:https://link.springer.com/article/10.1007/s00604-023-05743-w> (Year: 2023).
  • Abbott Diabetes Care, FreeStyle Libre 2 app, https://web.archive.org/web/20220523204654/https://www.freestyle.abbott/us-en/products/freestyle-libre-app.html (Captured by Internet Archive on May 23, 2022).
Patent History
Patent number: D1070887
Type: Grant
Filed: Nov 2, 2023
Date of Patent: Apr 15, 2025
Assignee: Abbott Diabetes Care Inc. (Alameda, CA)
Inventors: Andrew Mark Revoltar (Burien, WA), Cristina Congote González (Medellin), Sabine Kabel-Eckes (Mountain View)
Primary Examiner: Melanie H Tung
Assistant Examiner: Kyra S Buenaventura
Application Number: 29/915,709
Classifications
Current U.S. Class: Generated Image (D14/485)